Wang, H., Yang, J., Pan, H., Tai, M. C., Maher, M. H., Jia, R., . . . Lu, L. (2020). Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway. Onco Targets Ther.

Wang, Huixue, Jie Yang, Hui Pan, Mei Chee Tai, Mohamed H. Maher, Renbing Jia, Shengfang Ge, και Linna Lu. "Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway." Onco Targets Ther 2020.

Wang, Huixue, et al. "Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway." Onco Targets Ther 2020.